XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
CURRENT ASSETS:    
Cash and cash equivalents $ 98,867 $ 49,898
Security deposits and leasehold improvements 253 254
Prepaid expenses and other current assets 5,483 4,234
Total current assets 104,603 54,386
Operating lease right-of-use asset 1,963 447
TOTAL ASSETS 106,566 54,833
CURRENT LIABILITIES:    
Current portion of operating lease liabilities 264 429
Accounts payable 2,837 1,742
Accrued expenses and other current liabilities 13,489 15,286
Warrant liabilities 82,377 53,725
Total current liabilities 98,967 71,182
NONCURRENT LIABILITIES:    
Noncurrent portion of operating lease liabilities 1,707 38
Clinical holdback - long-term portion   759
Total noncurrent liabilities 1,707 797
Total liabilities 100,674 71,979
STOCKHOLDERS' EQUITY/(DEFICIT):    
Common stock, $0.0001 par value; 250,000,000 shares authorized as of September 30, 2024 and 200,000,000 shares authorized as of December 31, 2023; 116,356,474 shares issued and outstanding as of September 30, 2024 and 84,869,832 shares issued and outstanding as of December 31, 2023 11 8
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023
Additional paid-in capital 624,098 451,432
Accumulated deficit (618,217) (468,586)
Total stockholders' (deficit)/equity 5,892 (17,146)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIT) $ 106,566 $ 54,833